XJPX
4107
Market cap117mUSD
Jul 10, Last price
3,775.00JPY
1D
1.21%
1Q
-25.25%
Jan 2017
52.83%
Name
Ise Chemicals Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ISE Chemicals Corporation, a company primarily operating in Japan, specializes in the manufacturing, refinement, and distribution of iodine, its various derivatives, and compounds of cobalt and nickel. The company's iodine products are essential for a wide array of applications, including X-ray contrast agents, polarizing film production, disinfectants, catalysts, stabilizers, pharmaceutical ingredients, and diverse nutritional additives for both humans and animals. Its cobalt and nickel compounds are predominantly utilized in the creation of electronic components. Additionally, ISE Chemicals extends its operations to include the extraction and provision of natural gas, supplying it to gas utility companies and industrial facilities. Established in 1927, ISE Chemicals Corporation maintains its headquarters in Tokyo, Japan, and functions as a subsidiary of AGC Inc.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||